Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

年齢に伴い,皮質の骨の損失が増加します.

D G Ikkos, P Katsichtis, K Ntalles

    Lancet (London, England)
    |November 1, 1971
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Differential regulation of DNA damage response activation between somatic and germline cells in Caenorhabditis elegans.

    Cell death and differentiation·2012
    Same author

    NER and HR pathways act sequentially to promote UV-C-induced germ cell apoptosis in Caenorhabditis elegans.

    Cell death and differentiation·2010
    Same author

    Hypothyroidism - new aspects of an old disease.

    Hippokratia·2010
    Same author

    Vitamin D metabolism in thyrotoxicosis. Therapeutic aspects derived from an old observation.

    International journal of clinical practice·2009
    Same author

    The nucleotide excision repair pathway is required for UV-C-induced apoptosis in Caenorhabditis elegans.

    Cell death and differentiation·2007
    Same author

    Death and more: DNA damage response pathways in the nematode C. elegans.

    Cell death and differentiation·2003
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る